110 related articles for article (PubMed ID: 29383112)
21. Dysregulated microRNA expression in adenocarcinoma of the uterine cervix: clinical impact of miR-363-3p.
Park H; Lee MJ; Jeong JY; Choi MC; Jung SG; Joo WD; Lee C; An HJ
Gynecol Oncol; 2014 Dec; 135(3):565-72. PubMed ID: 25230213
[TBL] [Abstract][Full Text] [Related]
22. Identification of carcinogenic potential-associated molecular mechanisms in CD133(+) A549 cells based on microRNA profiles.
Chen QY; Jiao DM; Zhu Y; Hu H; Wang J; Tang X; Chen J; Yan L
Tumour Biol; 2016 Jan; 37(1):521-30. PubMed ID: 26227219
[TBL] [Abstract][Full Text] [Related]
23. Potential role of circulating microRNAs as a biomarker for unexplained recurrent spontaneous abortion.
Qin W; Tang Y; Yang N; Wei X; Wu J
Fertil Steril; 2016 May; 105(5):1247-1254.e3. PubMed ID: 26868995
[TBL] [Abstract][Full Text] [Related]
24. Hsa-miR-31-3p expression is linked to progression-free survival in patients with KRAS wild-type metastatic colorectal cancer treated with anti-EGFR therapy.
Manceau G; Imbeaud S; Thiébaut R; Liébaert F; Fontaine K; Rousseau F; Génin B; Le Corre D; Didelot A; Vincent M; Bachet JB; Chibaudel B; Bouché O; Landi B; Bibeau F; Leroy K; Penault-Llorca F; Van Laethem JL; Demetter P; Tejpar S; Rossi S; Mosakhani N; Osterlund P; Ristamäki R; Sarhadi V; Knuutila S; Boige V; André T; Laurent-Puig P
Clin Cancer Res; 2014 Jun; 20(12):3338-47. PubMed ID: 24771647
[TBL] [Abstract][Full Text] [Related]
25. Rodent heart failure models do not reflect the human circulating microRNA signature in heart failure.
Vegter EL; Ovchinnikova ES; Silljé HHW; Meems LMG; van der Pol A; van der Velde AR; Berezikov E; Voors AA; de Boer RA; van der Meer P
PLoS One; 2017; 12(5):e0177242. PubMed ID: 28475616
[TBL] [Abstract][Full Text] [Related]
26. MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab.
Mlcochova J; Faltejskova-Vychytilova P; Ferracin M; Zagatti B; Radova L; Svoboda M; Nemecek R; John S; Kiss I; Vyzula R; Negrini M; Slaby O
Oncotarget; 2015 Nov; 6(36):38695-704. PubMed ID: 26497852
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of miR-24-3p is a potentially adverse prognostic factor in colorectal adenocarcinoma.
Kerimis D; Kontos CK; Christodoulou S; Papadopoulos IN; Scorilas A
Clin Biochem; 2017 Apr; 50(6):285-292. PubMed ID: 27939727
[TBL] [Abstract][Full Text] [Related]
28. Expression profile of plasma microRNAs in nonsyndromic cleft lip and their clinical significance as biomarkers.
Zou J; Li J; Li J; Ji C; Li Q; Guo X
Biomed Pharmacother; 2016 Aug; 82():459-66. PubMed ID: 27470385
[TBL] [Abstract][Full Text] [Related]
29. Repression of Toll-like receptor-4 by microRNA-149-3p is associated with smoking-related COPD.
Shen W; Liu J; Zhao G; Fan M; Song G; Zhang Y; Weng Z; Zhang Y
Int J Chron Obstruct Pulmon Dis; 2017; 12():705-715. PubMed ID: 28260877
[TBL] [Abstract][Full Text] [Related]
30. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
[TBL] [Abstract][Full Text] [Related]
31. Exploration of inhibitory mechanisms of curcumin in lung cancer metastasis using a miRNA- transcription factor-target gene network.
Jiao DM; Yan L; Wang LS; Hu HZ; Tang XL; Chen J; Wang J; Li Y; Chen QY
PLoS One; 2017; 12(2):e0172470. PubMed ID: 28231299
[TBL] [Abstract][Full Text] [Related]
32. Selective secretion of microRNAs from lung cancer cells via extracellular vesicles promotes CAMK1D-mediated tube formation in endothelial cells.
Lawson J; Dickman C; MacLellan S; Towle R; Jabalee J; Lam S; Garnis C
Oncotarget; 2017 Oct; 8(48):83913-83924. PubMed ID: 29137392
[TBL] [Abstract][Full Text] [Related]
33. Circulating miRNAs is a potential marker for gefitinib sensitivity and correlation with EGFR mutational status in human lung cancers.
Zhao Q; Cao J; Wu YC; Liu X; Han J; Huang XC; Jiang LH; Hou XX; Mao WM; Ling ZQ
Am J Cancer Res; 2015; 5(5):1692-705. PubMed ID: 26175938
[TBL] [Abstract][Full Text] [Related]
34. Differential microRNA expression profiles between young and old lung adenocarcinoma patients.
Giordano M; Boldrini L; Servadio A; Niccoli C; Melfi F; Lucchi M; Mussi A; Fontanini G
Am J Transl Res; 2018; 10(3):892-900. PubMed ID: 29636879
[TBL] [Abstract][Full Text] [Related]
35. Relationship between the miRNA Profiles and Oncogene Mutations in Non-Smoker Lung Cancer. Relevance for Lung Cancer Personalized Screenings and Treatments.
Izzotti A; Coronel Vargas G; Pulliero A; Coco S; Vanni I; Colarossi C; Blanco G; Agodi A; Barchitta M; Maugeri A; Ct-Me-En Cancer Registry Workers ; Oliveri Conti G; Ferrante M; Sciacca S
J Pers Med; 2021 Mar; 11(3):. PubMed ID: 33807865
[TBL] [Abstract][Full Text] [Related]
36. Predisposition to Lung Adenocarcinoma in a Family Harboring the Germline
Ohtsuka K; Ohnishi H; Fujiwara M; Morii T; Matsushima S; Ogura W; Yamasaki S; Kishino T; Tanaka R; Watanabe T
JCO Precis Oncol; 2019; 3():. PubMed ID: 32914005
[No Abstract] [Full Text] [Related]
37. How to optimize the treatment strategy for patients with EGFR-mutant stage IA lung adenocarcinoma: an international multidisciplinary team.
Zhang Y; Shen J; Simone CB; Cappuzzo F; Fong KM; Rosell R; Chang JY; Ampollini L; Choi JI; He J; Jiang T;
J Thorac Dis; 2018 Jun; 10(6):3883-3890. PubMed ID: 30069390
[No Abstract] [Full Text] [Related]
38. New promising circulating RNA biomarkers for early diagnosis of lung adenocarcinoma.
Enguita FJ
Ann Transl Med; 2019 Jul; 7(Suppl 3):S130. PubMed ID: 31576337
[No Abstract] [Full Text] [Related]
39. Osimertinib resistance in non-small cell lung cancer: Mechanisms and therapeutic strategies.
Tang ZH; Lu JJ
Cancer Lett; 2018 Apr; 420():242-246. PubMed ID: 29425688
[TBL] [Abstract][Full Text] [Related]
40. Heterogeneity-based, multiple mechanisms in the resistance to osimertinib (AZD9291): A case report.
Liu Y; Hao X; Hu X; Li J; Wang Y; Wang H; Xing P; Li W; Ying J; Han X; Shi Y
Thorac Cancer; 2018 Apr; 9(4):498-501. PubMed ID: 29411527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
